TY - JOUR AU - Liu, Zhaonan AU - Li, Xingjie AU - He, Xuequn AU - Xu, Yingchun AU - Wang, Xi PY - 2019 DA - 2019/11/08 TI - Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report JO - BMC Cancer SP - 1062 VL - 19 IS - 1 AB - The majority of patients diagnosed with hepatocellular carcinoma (HCC) have advanced diseases and many are not eligible for curative therapies. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-019-6287-8 DO - 10.1186/s12885-019-6287-8 ID - Liu2019 ER -